Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 11/2017

01-11-2017 | Head and Neck

Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy

Authors: Gang Zheng, Hanzhang Lu, Wenkui Yu, Song Luo, Ya Liu, Wei Liu, Hui Liu, Long Wu, Lijuan Zheng, Xiang Kong, Long Jiang Zhang, Guang Ming Lu

Published in: European Radiology | Issue 11/2017

Login to get access

Abstract

Objectives

To assess how the severity of hepatic encephalopathy (HE) affects perfusion and metabolic changes in cirrhotic patients and the association between severity and liver disease and anemia.

Methods

The study groups comprised 31 healthy subjects and 33 cirrhotic patients who underwent MR examinations, and blood and neuropsychological tests. Of the cirrhotic patients, 14 were unaffected, and 11 had covert HE (CHE) and 8 overt HE (OHE). Global cerebral blood flow (CBF), oxygen extraction fraction (OEF), and metabolic rate of oxygen (CMRO2) were noninvasively measured by phase-contrast and T2-relaxation-under-spin-tagging MRI. Correlations were performed between MR measurements, hematocrits, ammonia levels, Child-Pugh scores and neuropsychological test scores.

Results

Compared with the values in healthy subjects, CBF was higher in unaffected patients, the same in CHE patients and lower in OHE patients, OEF was higher in all patients, and CMRO2 was the same in unaffected and CHE patients and lower in OHE patients. Hematocrit was negatively correlated with CBF and OEF, but not with CMRO2. Ammonia level was negatively correlated with CBF and CMRO2, and Child-Pugh score was negatively correlated with CMRO2.

Conclusions

The severity-associated alterations in cirrhotic patients indicate that homeostasis of oxygen delivery and oxidative metabolism in HE is regulated by multiple mechanisms. These physiological alterations appeared to be associated with the degree of anemia, ammonia level, and liver function.

Key Points

• CBF, OEF and CMRO2 did not change monotonically with HE progression.
• Anemia possibly contributed to CBF and OEF changes in cirrhotic patients.
• Liver dysfunction mainly contributed to changes in CMRO2 in cirrhotic patients.
Literature
1.
Vilstrup H, Amodio P, Bajaj J et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60:715–735CrossRef
2.
Lockwood AH, Yap EW, Rhoades HM, Wong WH (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11:331–336CrossRef
3.
Ahl B, Weissenborn K, van den Hoff J et al (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79CrossRef
4.
Iversen P, Sørensen M, Bak LK et al (2009) Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136:863–871CrossRef
5.
Gjedde A, Keiding S, Vilstrup H, Iversen P (2010) No oxygen delivery limitation in hepatic encephalopathy. Metab Brain Dis 25:57–63CrossRef
6.
Dam G, Keiding S, Munk OL et al (2013) Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology 57:258–265CrossRef
7.
O'Carroll RE, Hayes PC, Ebmeier KP et al (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337:1250–1253CrossRef
8.
Catafau AM, Kulisevsky J, Bernà L et al (2000) Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 41:405–410PubMed
9.
Yazgan Y, Narin Y, Demirturk L et al (2003) Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. J Gastroenterol Hepatol 18:1162–1167CrossRef
10.
Nakagawa Y, Matsumura K, Iwasa M, Kaito M, Adachi Y, Takeda K (2004) Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy. Ann Nucl Med 18:123–129CrossRef
11.
Iwasa M, Matsumura K, Nakagawa Y et al (2005) Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis. Metab Brain Dis 20:7–17CrossRef
12.
Zheng G, Zhang LJ, Cao Y, Lu GM (2013) Venous blood ammonia can be associated with cerebral blood flow in hepatic encephalopathy. Hepatology 58:832–833CrossRef
13.
Zheng G, Zhang LJ, Cao Y et al (2013) Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study. Metab Brain Dis 28:463–471CrossRef
14.
Felipo V, Urios A, Giménez-Garzó C et al (2014) Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests. World J Gastroenterol 20:11815–11825CrossRef
15.
Zheng G, Zhang LJ, Zhong J et al (2013) Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. Eur J Radiol 82:1981–1988CrossRef
16.
Testa R, Rodriguez G, Arvigo F et al (1989) Cerebral blood flow and plasma free tryptophan in cirrhotics with and without hepatic encephalopathy. Ital J Neurol Sci 10:415–421CrossRef
17.
Macías-Rodríguez RU, Duarte-Rojo A, Cantú-Brito C et al (2015) Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy. Liver Int 35:344–352CrossRef
18.
Ikeda K, Tsuji H, Azuma K et al (2001) Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography. Fukuoka Igaku Zasshi 92:306–314PubMed
19.
Xu F, Ge Y, Lu H (2009) Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62:141–148CrossRef
20.
Lu H, Ge Y (2008) Quantitative evaluation of oxygenation in venous vessels using T2-relaxation-under-spin-tagging MRI. Magn Reson Med 60:357–363CrossRef
21.
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721CrossRef
22.
Córdoba J, Mínguez B (2008) Hepatic encephalopathy. Semin Liver Dis 28:70–80CrossRef
23.
Duarte-Rojo A, Estradas J, Hernández-Ramos R, Ponce-de-León S, Córdoba J, Torre A (2011) Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci 56:3014–3023CrossRef
24.
Zheng G, Wen J, Lu H et al (2016) Elevated global cerebral blood flow, oxygen extraction fraction and unchanged metabolic rate of oxygen in young adults with end-stage renal disease: an MRI study. Eur Radiol 26:1732–1741CrossRef
25.
Haccke EM, Brown RW, Thompson MR, Venkatesan R (1999) MR angiography and flow quantification. magnetic resonance imaging: physical principles and sequence design. Wiley-Liss, New York
26.
Sheng M, Lu H, Liu P, Thomas BP, McAdams CJ (2015) Cerebral perfusion differences in women currently with and recovered from anorexia nervosa. Psychiatry Res 232:175–183CrossRef
27.
Jordan LC, Gindville MC, Scott AO et al (2016) Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia. Brain 139:738–750CrossRef
28.
Hayashi T, Watabe H, Kudomi N et al (2003) A theoretical model of oxygen delivery and metabolism for physiologic interpretation of quantitative cerebral blood flow and metabolic rate of oxygen. J Cereb Blood Flow Metab 23:1314–1323CrossRef
29.
Hayashi T, Kudomi N, Teramoto N et al (2004) A physiological model for cerebral oxygen delivery and consumption and effective oxygen diffusibility evaluated by PET. Int Congr Ser 1265:228–237CrossRef
30.
Gjedde A, Johannsen P, Cold GE, Ostergaard L (2005) Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition. J Cereb Blood Flow Metab 25:1183–1196CrossRef
31.
Guevara M, Bru C, Ginès P et al (1998) Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology 28:39–44CrossRef
32.
Ginès P, Kamath PS, Arroyo V (2011) Chronic liver failure: mechanisms and management. Humana Press, TotowaCrossRef
33.
Tarantino G, Citro V, Esposito P et al (2009) Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol 9:21CrossRef
Metadata
Title
Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy
Authors
Gang Zheng
Hanzhang Lu
Wenkui Yu
Song Luo
Ya Liu
Wei Liu
Hui Liu
Long Wu
Lijuan Zheng
Xiang Kong
Long Jiang Zhang
Guang Ming Lu
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 11/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-4809-9

Other articles of this Issue 11/2017

European Radiology 11/2017 Go to the issue

Physics

Do we need 3D tube current modulation information for accurate organ dosimetry in chest CT? Protocols dose comparisons

Chest

Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification

Chest

Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules

Neuro

Comparison of 3D magnetic resonance imaging and digital subtraction angiography for intracranial artery stenosis

Breast

The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review

Musculoskeletal

Differences in tibial subchondral bone structure evaluated using plain radiographs between knees with and without cartilage damage or bone marrow lesions - the Oulu Knee Osteoarthritis study